Zachary M. Johns represents US and international clients in a variety of high-stakes complex commercial matters with a focus on civil and criminal antitrust and class action litigation. He also counsels businesses on antitrust and litigation risks and advises on risk management strategies. Zak represents companies across a broad range of industries, including financial services, pharmaceutical, food manufacturing, consumer products, aviation, and building products.
Zak has experience handling complex single plaintiff and class actions from inception through trial and appeal. As part of his litigation practice, Zak recently co-chaired an eleven day trial in which he delivered the opening statement and conducted multiday examinations of two key witnesses. Zak also maintains an active pro bono practice and volunteers for the Philadelphia Volunteer Lawyers for the Arts program as well as the HIAS division in Philadelphia. He also serves on the board of trustees of the nonprofit Philadelphia Youth Orchestra, the area’s premier youth orchestra for gifted, young, classical musicians. While in law school, Zak worked as a summer intern for Judge Gene E.K. Pratter of the US District Court for the Eastern District of Pennsylvania and participated in a legal clinic representing low-income individuals in family law matters.
Zak also participates in the ABA’s Antitrust Section, is a member of the firm’s Class Action Working Group, and is a contributor to the Morgan Lewis Year-End and Mid-Year Cartel Enforcement Reports.
Zak’s current litigation matters include:
Defending a leading vaccine manufacturer against a putative class action alleging Sherman Act Section 2 violations and related state law claims.
Defending a generic pharmaceutical manufacturer in a grand jury investigation regarding alleged price fixing and market allocation.
Representing a leading owner of derivatives exchanges in prosecuting Sherman Act Section 1 and 2 claims relating to anticompetitive conduct that prevented market entry of a competing US-based exchange for derivatives.
Defending a leading cable television and multimedia companyagainst Sherman Act Section 1 conspiracy claims brought by cable installers.
Defending manufacturer of aviation products against Sherman Action Section 2 conspiracy to monopolize and various state law antitrust and state law tort claims.
Defending manufacturer of automotive components against Sherman Act Section 1 conspiracy claims brought by direct and indirect purchasers.
Secured a Rule 12 dismissal with prejudice of attempted monopolization claim under Section 2 of the Sherman Act against a leading transportation network company arising out of the launch of operations in Philadelphia.
Secured a Rule 12 dismissal with prejudice of exclusive dealing and conspiracy claims under Section 1 of the Sherman Act against leading managed care provider.
Secured a favorable resolution to claims under Sections 1 and 2 of the Sherman Act against a leading hospital system arising out of supposedly exclusive agreement pertaining to advanced cardiac services.
Obtained a dismissal of state law claims brought against a manufacturer of heavy equipment by a terminated distributor.
Secured Rule 12 dismissals of claims against a manufacturer of gas piping in numerous consumer fraud and product liability class actions in state and federal courts nationwide.
Favorable resolved failure-to-warn and consumer fraud claims against manufacturer of herbal products.
Successfully defended bottled water manufacturer against claims that bottled water products failed to warn of risks associated with fluoride. The first complaint was dismissed without leave to amend on the basis of federal preemption under the Nutritional Labeling and Education Act.
Represented aviation parts manufacturer in defense of theft of trade secrets claim and in prosecution of abuse of process and malicious prosecution counterclaims.
Represented a pharmaceutical manufacturer before the Judicial Panel on Multidistrict Litigation.
Zak’s representative counseling includes:
Counseled medical product manufacturer on potential antitrust risks from potential patent settlement agreement.
Counseled leading pharmaceutical manufacturer on litigation risks posed by portfolio of patent settlement agreements.
Developed risk assessment guidance and drafted warning labels for various manufacturers of consumer products.
Drexel University, 2009, B.S., Summa Cum Laude
University of Illinois College of Law, 2012, J.D., Summa Cum Laude
US Court of Appeals for the Fourth Circuit
US Court of Appeals for the Seventh Circuit
US District Court for the Eastern District of Pennsylvania
US District Court for the District of New Jersey
Awards and Affiliations
Member, Practice Group of the Year, Competition, Law360 (2017)
Listed, Pennsylvania Super Lawyers "Rising Star" in Antitrust Litigation (2015–2017)
Member, American Bar Association
Member, Pennsylvania Bar Association
Member, Philadelphia Bar Association
Member, Order of the Coif
Executive Editor, University of Illinois Law Review
Recipient, Rickert Award for Academic Excellence (2012)
Recognized, US News & World Report and Best Lawyers 2017 Practice Group of the Year for Antitrust Law